"This study revealed that exertional dyspnea, exertional palpitations, and decreased nailfold capillary density (≤ seven/mm) serve as useful indicator for considering exercise [right heart ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The ...

March 6 (Reuters) - Merck & Co Inc (MRK.N), opens new tab said on Monday its experimental therapy helped increase exercise capacity in patients with a deadly disease that causes high pressure in blood ...

As the world marks Rare Disease Month, health experts are urging greater awareness of conditions that often go unnoticed ...

Pulmonary hypertension (PH) is a complex and often misunderstood condition characterized by high blood pressure in the arteries of the lungs. Unlike systemic hypertension – the "regular" high blood ...

Please provide your email address to receive an email when new articles are posted on . Sublingual nitroglycerin reduced pulmonary capillary wedge pressure in patients with HF with preserved ejection ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.